United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 20, 2026 · Filed May 21, 2026

On May 20, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$565.98 for US$5.38M under a trading plan, leaving 40,513 shares. Filed May 21, 2026 (Form 4).

Sold
9,500 shares
Price
US$565.98 average (US$562.01 to US$577.26)
Value
US$5.38M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 20, 2026Common StockSale440US$562.0149,573Direct
May 20, 2026Common StockSale2,071US$562.9447,502Direct
May 20, 2026Common StockSale1,949US$563.9745,553Direct
May 20, 2026Common StockSale1,280US$564.8144,273Direct
May 20, 2026Common StockSale840US$565.9543,433Direct
May 20, 2026Common StockSale280US$566.8943,153Direct
May 20, 2026Common StockSale412US$568.3442,741Direct
May 20, 2026Common StockSale660US$569.3042,081Direct
May 20, 2026Common StockSale552US$570.3841,529Direct
May 20, 2026Common StockSale376US$571.4141,153Direct
May 20, 2026Common StockSale195US$573.0040,958Direct
May 20, 2026Common StockSale245US$574.0840,713Direct
May 20, 2026Common StockSale200US$577.2640,513Direct

Source

View original at SEC

Related